The Department of Urology at First Affiliated Hospital of Chongqing Medical University was established in 1957 under the leadership of Professor CHEN Jiabiao, who, along with several urologists from the former Shanghai Medical College, relocated to Chongqing. Over several generations, the department has continuously improved its overall medical service capacity and quality, developing a comprehensive medical system that integrates clinical care, teaching, research, and preventive healthcare. It is now the largest urology specialty department in Chongqing and serves as the city’s center for the diagnosis and treatment of complex and critical urological diseases. The department is also a key unit in multiple academic organizations, serving as a permanent member of the Urology Branch of the Chinese Medical Association, a permanent member of the Chinese Association of Integrative Medicine, and the chairman unit of the Urology Branch of the Chongqing Medical Association.
The department currently has 19 senior-level professionals, 7 associate senior professionals, 7 doctoral supervisors, and 22 master supervisors. Additionally, it also includes 7 provincial and ministerial-level talents, and 9 postdoctoral fellows. The department has been awarded 26 national-level research projects, including one major project from the Ministry of Science and Technology and one sub-project. In recent years, it has published 15 papers in top-tier journals (with impact factors over 10 or in the first quartile of the Chinese Academy of Sciences) and 55 papers in journals ranked in the second or higher quartiles. The department has also received the Third Prize of the Chinese Medical Science and Technology Award, First and Second prizes in the Chongqing Medical Science and Technology Achievement Awards, and three Third Prizes in Chongqing’s Science and Technology Progress.
The department has complete functional facilities, featuring three general urology wards and one organ transplant ward, totaling 202 beds. It operates seven clinical treatment centers: Urological Oncology Diagnosis and Treatment Center, Urolithiasis Diagnosis and Treatment Center, General Urology Disease Center, Organ Transplant Center, Andrology Center (Chongqing’s Andrology Diagnosis and Treatment Center), Female (Pelvic Floor) Urology Disease Center, and Extracorporeal Shock Wave Lithotripsy Center and Laboratory. New techniques introduced include sacral nerve stimulator implantation, total laparoscopic nephroureterectomy, prostate lifting surgery, robot-assisted laparoscopic ureteroplasty with lip mucosa transplantation, and sacral nerve modulation. Key strengths comprise robot-assisted complex urological oncology surgeries, and the combined use of a flexible ureteroscope with an intelligent pressure control system for kidney stone fragmentation and extraction.
The department routinely performs percutaneous nephroscopy and ureteroscopy for the treatment of multiple kidney stones, stag-horn stones, ureteral stones, and bladder stones. Robot-assisted laparoscopic surgeries include radical nephrectomy, partial nephrectomy, radical pyeloureterectomy, adrenal tumor resections (for conditions such as pheochromocytoma, primary aldosteronism, and Cushing’s syndrome), prostate cancer radical prostatectomy, total cystectomy with urinary diversion, prostate electrosurgery, cold knife urethrotomy for urethral strictures, oral mucosa transplantation urethroplasty, surgical procedures for stress urinary incontinence (including TVT, TVT-O, TOT, and single-incision suspension techniques), various malformation corrections, sacral nerve modulation, pelvic floor repairs, precision diagnosis and systematic treatment of PE and ED, as well as various open surgeries. The comprehensive capabilities of the department have propelled it to the forefront of domestic urology, with several techniques approaching international advanced levels.